Perspective Back to Top Jonathan Terry, DO, QME, DABPN, ABIHM In reviewing this research, I find myself with more questions than answers. I wonder what criteria might have led a patient to be more likely to be prescribed a GLP-1 medication than not and if this led to any type of selection bias when looking at outcomes for depression and anxiety. I am curious if barriers to payment for a GLP-1 medication might predispose a patient to be more likely to develop depression or anxiety.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Jonathan
Contact Jonathan, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack